Health and Medicine
-
May 21, 2015
Study to explore optimal daily aspirin dose for heart health
The Vanderbilt-based Mid-South Clinical Data Research Network (CDRN) is among seven CDRNs that will collaboratively mount a three-year, $14 million randomized clinical trial to determine the best daily dose of aspirin for preventing heart attacks and strokes among people living with heart disease. -
May 20, 2015
Preventing early pregnancy complications
The enzyme alkaline phosphatase may provide a new therapeutic option for women at high risk of pregnancy complications due to bacterial toxin exposure. -
May 18, 2015
Tools for exploring ‘omics’ data
The NetGestalt computing portal integrates vast amounts of data to aid users in finding biologically and clinically relevant information. -
May 15, 2015
Boosting cell-based heart repair
A metabolic change in adult stem cells makes them less “fit” for regenerative heart therapies, suggesting that strategies to prevent this response may boost the therapeutic usefulness of the cells. -
May 14, 2015
Jansen’s cancer research efforts garner recognition
Valerie Malyvanh Jansen, M.D., Ph.D., a third-year medical oncology fellow, recently received several national awards and grants, as well as a Vanderbilt-Ingram Cancer Center fellowship, in recognition of her translational cancer research. -
May 14, 2015
Insights on lysosomal storage diseases
A novel mechanism could point to new therapies for a group of inherited diseases that share pathological features. -
May 7, 2015
Grant spurs study of rare breathing condition in women
A research team at Vanderbilt University Medical Center has been approved for a $2.7 million funding award by the Patient-Centered Outcomes Research Institute (PCORI) to study idiopathic subglottic stenosis (iSGS), a rare condition that inexplicably causes middle-aged women to struggle to breathe.